Meta-analysis of antithrombotic therapy with new oral anticoagulants in patients with atrial fibrillation after percutaneous coronary intervention.
作者信息
Siddiqi Rabbia, Yamani Naser, Alnaimat Saed, Khurshid Aiman, Siddiqui Sadia, Khan Mohammad Saud, Khan Safi U
机构信息
Dow Medical College, Dow University of Health Sciences, Pakistan.
Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
出版信息
Eur J Prev Cardiol. 2020 Dec;27(19):2119-2122. doi: 10.1177/2047487319865048. Epub 2019 Jul 26.
Abstract
摘要
相似文献
1
Meta-analysis of antithrombotic therapy with new oral anticoagulants in patients with atrial fibrillation after percutaneous coronary intervention.经皮冠状动脉介入治疗后房颤患者使用新型口服抗凝药进行抗血栓治疗的荟萃分析
Eur J Prev Cardiol. 2020 Dec;27(19):2119-2122. doi: 10.1177/2047487319865048. Epub 2019 Jul 26.
2
Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗的心房颤动患者的抗血栓治疗。
Cardiol Clin. 2020 Nov;38(4):551-561. doi: 10.1016/j.ccl.2020.07.006. Epub 2020 Sep 17.
3
And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?现在我们有了AUGUSTUS研究……它将如何影响接受经皮冠状动脉介入治疗的房颤患者的抗栓治疗？
Eur J Intern Med. 2019 Jul;65:1-3. doi: 10.1016/j.ejim.2019.05.019. Epub 2019 May 23.
4
Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.应对心房颤动合并冠状动脉疾病患者抗栓治疗的复杂局面：来自AUGUSTUS研究的经验教训
Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.
5
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
6
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.房颤合并冠状动脉疾病患者的三联与双联抗栓治疗
Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.
7
Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗的心房颤动患者抗栓治疗的荟萃分析。
Am J Cardiol. 2020 Feb 15;125(4):521-527. doi: 10.1016/j.amjcard.2019.11.022. Epub 2019 Nov 19.
8
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.急性冠状动脉综合征或经皮冠状动脉介入治疗后早期和晚期心房颤动患者抗栓治疗的风险/获益权衡：来自 AUGUSTUS 的见解。
Circulation. 2020 May 19;141(20):1618-1627. doi: 10.1161/CIRCULATIONAHA.120.046534. Epub 2020 Mar 29.
9
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials.心房颤动合并急性冠状动脉综合征/经皮冠状动脉介入治疗试验中双重抗栓治疗相关的支架内血栓形成
J Am Coll Cardiol. 2020 Apr 14;75(14):1727-1728. doi: 10.1016/j.jacc.2020.01.054.
10
[Recent advances in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention].[接受经皮冠状动脉介入治疗的冠心病患者抗血栓治疗的最新进展]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Feb 24;49(2):108-110. doi: 10.3760/cma.j.cn112148-20201222-01010.
本文引用的文献
1
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.心房颤动急性冠状动脉综合征或经皮冠状动脉介入治疗后的抗血栓治疗。
N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
3
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.经皮冠状动脉介入治疗后心房颤动患者双联与三联抗栓治疗的安全性和有效性：随机临床试验的系统评价和荟萃分析。
Eur Heart J. 2018 May 14;39(19):1726-1735a. doi: 10.1093/eurheartj/ehy162.
4
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.2018 年欧洲心脏病学会实用指南：非维生素 K 拮抗剂口服抗凝剂在心房颤动患者中的应用：执行摘要。
Europace. 2018 Aug 1;20(8):1231-1242. doi: 10.1093/europace/euy054.
5
Meta-Analysis of Antithrombotic Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后心房颤动抗栓治疗的Meta分析
Am J Cardiol. 2018 May 15;121(10):1200-1206. doi: 10.1016/j.amjcard.2018.01.036. Epub 2018 Feb 14.
6
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.比较接受经皮冠状动脉介入治疗的房颤患者双联与三联抗栓治疗安全性和有效性的Meta分析
Am J Cardiol. 2018 Mar 15;121(6):718-724. doi: 10.1016/j.amjcard.2017.12.014. Epub 2017 Dec 25.
7
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.房颤患者 PCI 术后的达比加群双重抗血栓治疗。
N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.
8
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.缺血性心脏病二级预防中的抗血小板和抗血栓治疗。
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):61-70. doi: 10.1177/2047487317707854.
9
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.经皮冠状动脉介入治疗（PCI）的房颤患者的出血预防。
N Engl J Med. 2016 Dec 22;375(25):2423-2434. doi: 10.1056/NEJMoa1611594. Epub 2016 Nov 14.
Zotero 插件